Medipines

Yorba Linda, United States Founded: 2014 • Age: 12 yrs
Non-invasive respiratory measurement devices are developed for gas exchange assessment.

About Medipines

Medipines is a Healthcare company based in Yorba Linda (United States) founded in 2014. Non-invasive respiratory measurement devices are developed for gas exchange assessment. Medipines has raised $2.56 million across 2 funding rounds. Medipines offers products and services including AGM100. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Monitoring Devices. Its legal entity is MediPines Corporation. Its competitors include Apieron, Spirosure and Linshom; 3 of its 3 listed competitors have raised funding.

Company details

Medipines was founded in 2014 and is located in Yorba Linda, United States. A non-invasive device for respiratory measurement is being developed in the medical technology sector. Direct gas exchange data is captured to support respiratory detection and assessment. Parameters such as respiratory rate, respiratory quotient, and barometric pressure are measured through the devices operations, aiding clinical evaluations in respiratory health.

  • Headquarters Yorba Linda, United States
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website medipines.com
  • Social LinkedIn Facebook YouTube
  • Legal Name Medipines Corporation
Operational Areas
Key Metrics
  • Total Equity Funding
    $2.56M (USD)

    in 2 rounds

  • Latest Funding Round
    $2M (USD), Seed

    Jun 2017

Products & Services of Medipines

Medipines offers a comprehensive portfolio of products and services, including AGM100.

AGM100
Medical Device

Non-invasive tool for fast cardiorespiratory status assessment

Apps and channels of Medipines

its YouTube channel MediPines Corporation has 38 subscribers and 5 videos.

MediPines Corporation
YouTube 38 subscribers 5 videos Film & Animation
Open channel

Videos from Medipines

The most watched videos on Medipines's YouTube channel, MediPines Corporation (38 subscribers). Click a video to play it here.

MediPines AGM100
1.3K views
John B. West Distinguished Lecture Series - Inaugural Lecture
478 views
Dr. John B. West on COVID-19 and MediPines AGM100
352 views
Frontline: AGM100 Use In COVID-19
347 views

More on MediPines Corporation.

Funding Insights of Medipines

Medipines has successfully raised a total of $2.56M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.56M
  • Total Rounds 2
  • Last Round Seed — $2M
  • First Round $563,000

    (Mar 2015)

All 2 funding rounds of Medipines with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2017$2MSeed––
–
Mar 2015$563,000Seed––
–

People of Medipines

7 people are tracked at Medipines (3 in leadership, 4 in board & advisors).

NameRoleGroup
Steve Lee
CEOLeadership
Andrew McFadden
Director of MarketingLeadership
Youngjae Lee
Director Of EngineeringLeadership
Gary C. Sieck
AdvisorBoard & advisors
Phillip Ainslie
AdvisorBoard & advisors
John B. West
Medical Advisory ChairBoard & advisors
George M. Zlupko
AdvisorBoard & advisors
Premium access

Complete people profiles for Medipines

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Medipines

3 dated milestones of Medipines across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Medipines is founded.
  2. Funding First funding round of $563K.
  3. Funding Latest funding round, Seed, of $2.0M.

Competitors of Medipines

Medipines has 3 listed competitors in our database, 3 of them funded. They include Apieron, Spirosure and Linshom.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
apieron.com2001Menlo Park, United States$68.52M
Functions as an asthma monitoring device for health management.
spirosure.com2011Pleasanton, United States$50M12
Non-invasive breathalyzers are developed for pulmonary disease monitoring.
linshomforlife.com2009Ellicott, United States$3.35M
Developer of respiratory monitoring devices
Premium access

Detailed competitors of Medipines

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Medipines

The website of Medipines (medipines.com) receives about 1.2K visits a month.

  • Monthly visits
    1.2K

    ▲ 26.9% vs previous month

Top companies in Pulmonology

3 companies that operate in the same segment as Medipines (Pulmonology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of novel protein-based therapeutics using machine learning and biological engineering
2018Somerville, Massachusetts, United StatesUSD 693 M329
Portable oxygen concentrators are supplied for respiratory therapy needs.
2001Goleta, California, United StatesUSD 51.65 MUSD 348.67 M766
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M91
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Medipines

Premium access

Complete news archive for Medipines

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Medipines

Medipines was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Medipines is headquartered in Yorba Linda, United States. It is registered at Yorba Linda, California, United States.

Medipines is a funded company, having raised a total of $2.56M across 2 funding rounds to date. The company's 1st funding round was a Seed of $563K, raised on Mar 2015.

Medipines was founded in 2014 and is located in Yorba Linda, United States. A non-invasive device for respiratory measurement is being developed in the medical technology sector. Direct gas exchange data is captured to support respiratory detection and assessment. Parameters such as respiratory rate, respiratory quotient, and barometric pressure are measured through the devices operations, aiding clinical evaluations in respiratory health.

Medipines's top competitors include Linshom, Spirosure and Apieron.

Medipines offers AGM100.

Medipines operates through Medipines Corporation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available